$15.00
Min. Order : 1 Gram
$12.00
10-99 Grams
$9.00
100-999 Grams
$6.00
>=1000 Grams

Factory supply High Quality API raw material Powder Zonisamide powder CAS:68291-97-4 Pharmaceutical

Trade Assurance
Built-in order protection service in alibaba.com
Product quality
On-time shipment
More on shipping and other trade services.

Quick Details

Port: China Main Port
Payment Terms: L/C,D/A,D/P,T/T,Western Union,MoneyGram,Alipay
Supply Ability: 2000 Kilogram/Kilograms per Month Zonisamide
Other Names: Zonisamide
Usage: Animal Pharmaceuticals
Molecular Weight: 287.357
Place of Origin: Shaanxi China
Grade Standard: Medicine Grade,Tech Grade
Color: White
Product Name: Zonisamide
Purity: 99%min
Factory: Yes
Shelf life: 2 Years Proper Storage
Model Number: HNB-Zonisamide
MOQ: 1 KG
CAS No.: 68291-97-4
SAMPLE: 5g-10g free
Assay: HPLC 99%
Brand Name: HNB
Type: Cardiovascular Agents,Central Nervous System Agents
EINECS No.: n/a
MF: C8H8N2O3S
Application: Pharmaceutical Raw Intermediates
Certificate: GMP/ISO9001
Packaging Detail: Zonisamide 25kg/bag 25kg/drum 25kg/carton or as your requirement
Xi'an Harmonious Natural Biotechnology Co., Ltd.
Gold Supplier
CN
Trading Company
95%
Response Rate
68.0%
On-time delivery rate
US$ 70,000+
59
Transactions
-
Employees
-
R&D staffs
-
Patents
Visit Store

Factory supply High Quality API Powder Zonisamide powder CAS:68291-97-4banner

Product Description

 

Name Zonisamide
Molecular Formula C8H8N2O3S
Molecular Weight 212.226
CAS Registry Number 68291-97-4
density 1.5±0.1 g/cm3
Appearance white powder
EINECS n/a
Category API

Zonisamide is a white to slightly yellow crystalline or crystalline powder, odorless and bitter. Very soluble in acetone, soluble in methanol, ethanol, ethyl acetate or acetic acid, slightly soluble in water, n-hexane, ether or chloroform. Chinese alias 1,2-phenylisoxazole-3-methanesulfonamide; molecular formula: C8H8N2O3S; for epileptic seizures, small episodes, localized seizures, status epilepticus and psychomotor seizures.

Zonisamide.jpg

Functions of  Zonisamide

Zonisamide is a benzisoxazole derivative that inhibits epileptic foci and blocks the spread of seizure discharge. It is used to treat epilepsy that is ineffective for other medical treatments, especially partial seizures. It is effective for primary generalized seizures, mixed epilepsy, myoclonic seizures, and epilepsy syndromes such as Lun-Plus syndrome and West syndrome. But it is often used as an adjunct to other first-line drugs.

COA OF  Zonisamide

 Zonisamide coa.png

Advantage.jpgPackage.jpgshipping.jpg--1.jpg

 

--2.jpg

FeedbackID.jpg